Literature DB >> 11158221

Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice.

Minoru Satoh1, Naoki Kashihara2, Yasushi Yamasaki1, Keisuke Maruyama1, Kazunori Okamoto1, Youhei Maeshima1, Hitoshi Sugiyama1, Takeshi Sugaya3, Kazuo Murakami4, Hirofumi Makino1.   

Abstract

Unilateral ureteral obstruction (UUO) results in tubulointerstitial fibrosis of the affected kidney by stimulating the renin-angiotensin system. This study established a UUO model in angiotensin type 1a receptor (AT1a) deficient (mutant) mice to elucidate the role of angiotensin II through AT1a on the fibrosis of the obstructed kidney (OBK). The relative volume of the tubulointerstitium was measured by an image analyzer; deposition of collagen types III and IV and monocyte/macrophage infiltration were histologically examined using specific antibodies. Also determined were the mRNA levels of transforming growth factor-beta by Northern blot analysis. Nuclear factor-kappaB activity was assessed by gel shift assay. UUO in wild mice resulted in a marked expansion of relative volume of the tubulointerstitium, together with increased deposition of collagen types III and IV and number of infiltrated monocytes/macrophages in the interstitium, relative to sham-operated mice. In comparison, these changes were significantly lower in mutant mice with UUO. The mRNA level of transforming growth factor-beta was significantly higher in the OBK of wild mice with UUO compared with sham-operated mice. In contrast, the increase in mRNA level in the OBK of mutant mice was significantly less than in wild mice. Finally, UUO resulted in activation of nuclear factor-kappaB in wild mice but was inhibited in the OBK of mutant mice. The results provide direct evidence that angiotensin II acting via the AT1a plays a pivotal role in the development of tubulointerstitial fibrosis in UUO.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158221     DOI: 10.1681/ASN.V122317

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  51 in total

1.  Unexpected news in renal fibrosis.

Authors:  Juan A Oliver
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 2.  TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.

Authors:  Rohan Samarakoon; Jessica M Overstreet; Stephen P Higgins; Paul J Higgins
Journal:  Cell Tissue Res       Date:  2011-06-04       Impact factor: 5.249

3.  Identification and regulation of reticulon 4B (Nogo-B) in renal tubular epithelial cells.

Authors:  Ethan P Marin; Gilbert Moeckel; Rafia Al-Lamki; John Bradley; Qingshang Yan; Tong Wang; Paulette L Wright; Jun Yu; William C Sessa
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

4.  Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis.

Authors:  Masashi Nishida; Hidehiko Fujinaka; Taiji Matsusaka; James Price; Valentina Kon; Agnes B Fogo; Jeffrey M Davidson; MacRae F Linton; Sergio Fazio; Toshio Homma; Hiroaki Yoshida; Iekuni Ichikawa
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 5.  Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease.

Authors:  Jianhua He; Yong Xu; Daisuke Koya; Keizo Kanasaki
Journal:  Clin Exp Nephrol       Date:  2013-02-21       Impact factor: 2.801

6.  Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling.

Authors:  Minoru Satoh; Hajime Nagasu; Yoshitaka Morita; Terry P Yamaguchi; Yashpal S Kanwar; Naoki Kashihara
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-03

7.  In vivo bradykinin B2 receptor activation reduces renal fibrosis.

Authors:  Joost P Schanstra; Eric Neau; Pascale Drogoz; Miguel A Arevalo Gomez; José Miguel Lopez Novoa; Denis Calise; Christiane Pecher; Michael Bader; Jean-Pierre Girolami; Jean-Loup Bascands
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

8.  Requirement of Rac1 in the development of cardiac hypertrophy.

Authors:  Minoru Satoh; Hisakazu Ogita; Kyosuke Takeshita; Yasushi Mukai; David J Kwiatkowski; James K Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

9.  A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade.

Authors:  Hirokazu Okada; Tsutomu Inoue; Tomohiro Kikuta; Yusuke Watanabe; Yoshihiko Kanno; Shinichi Ban; Takeshi Sugaya; Masatsugu Horiuchi; Hiromichi Suzuki
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 10.  Obstructive nephropathy: insights from genetically engineered animals.

Authors:  Jean-Loup Bascands; Joost P Schanstra
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.